Found 5 hits for monomerid = 50533815 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Aurora kinase B
(Homo sapiens (Human)) | BDBM50533815
(CHEMBL4434704)Show SMILES COc1ccc2NC(=O)C(=Cc3ccc4c(n[nH]c4c3)-c3ccc(nc3)N3CCN(C)CC3)c2c1 Show InChI InChI=1S/C27H26N6O2/c1-32-9-11-33(12-10-32)25-8-4-18(16-28-25)26-20-6-3-17(14-24(20)30-31-26)13-22-21-15-19(35-2)5-7-23(21)29-27(22)34/h3-8,13-16H,9-12H2,1-2H3,(H,29,34)(H,30,31)/b22-13+ | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
EntreMed Inc.
Curated by ChEMBL
| Assay Description Inhibition of AURKB (unknown origin) |
Bioorg Med Chem Lett 26: 4625-4630 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.063 |
More data for this Ligand-Target Pair | |
Serine/threonine-protein kinase PLK4
(Homo sapiens (Human)) | BDBM50533815
(CHEMBL4434704)Show SMILES COc1ccc2NC(=O)C(=Cc3ccc4c(n[nH]c4c3)-c3ccc(nc3)N3CCN(C)CC3)c2c1 Show InChI InChI=1S/C27H26N6O2/c1-32-9-11-33(12-10-32)25-8-4-18(16-28-25)26-20-6-3-17(14-24(20)30-31-26)13-22-21-15-19(35-2)5-7-23(21)29-27(22)34/h3-8,13-16H,9-12H2,1-2H3,(H,29,34)(H,30,31)/b22-13+ | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.40 | n/a | n/a | n/a | n/a | n/a | n/a |
EntreMed Inc.
Curated by ChEMBL
| Assay Description Inhibition of PLK4 (unknown origin) |
Bioorg Med Chem Lett 26: 4625-4630 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.063 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50533815
(CHEMBL4434704)Show SMILES COc1ccc2NC(=O)C(=Cc3ccc4c(n[nH]c4c3)-c3ccc(nc3)N3CCN(C)CC3)c2c1 Show InChI InChI=1S/C27H26N6O2/c1-32-9-11-33(12-10-32)25-8-4-18(16-28-25)26-20-6-3-17(14-24(20)30-31-26)13-22-21-15-19(35-2)5-7-23(21)29-27(22)34/h3-8,13-16H,9-12H2,1-2H3,(H,29,34)(H,30,31)/b22-13+ | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 630 | n/a | n/a | n/a | n/a | n/a | n/a |
EntreMed Inc.
Curated by ChEMBL
| Assay Description Inhibition of KDR (unknown origin) |
Bioorg Med Chem Lett 26: 4625-4630 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.063 |
More data for this Ligand-Target Pair | |
Aurora kinase A
(Homo sapiens (Human)) | BDBM50533815
(CHEMBL4434704)Show SMILES COc1ccc2NC(=O)C(=Cc3ccc4c(n[nH]c4c3)-c3ccc(nc3)N3CCN(C)CC3)c2c1 Show InChI InChI=1S/C27H26N6O2/c1-32-9-11-33(12-10-32)25-8-4-18(16-28-25)26-20-6-3-17(14-24(20)30-31-26)13-22-21-15-19(35-2)5-7-23(21)29-27(22)34/h3-8,13-16H,9-12H2,1-2H3,(H,29,34)(H,30,31)/b22-13+ | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 700 | n/a | n/a | n/a | n/a | n/a | n/a |
EntreMed Inc.
Curated by ChEMBL
| Assay Description Inhibition of AURKA (unknown origin) |
Bioorg Med Chem Lett 26: 4625-4630 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.063 |
More data for this Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50533815
(CHEMBL4434704)Show SMILES COc1ccc2NC(=O)C(=Cc3ccc4c(n[nH]c4c3)-c3ccc(nc3)N3CCN(C)CC3)c2c1 Show InChI InChI=1S/C27H26N6O2/c1-32-9-11-33(12-10-32)25-8-4-18(16-28-25)26-20-6-3-17(14-24(20)30-31-26)13-22-21-15-19(35-2)5-7-23(21)29-27(22)34/h3-8,13-16H,9-12H2,1-2H3,(H,29,34)(H,30,31)/b22-13+ | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
EntreMed Inc.
Curated by ChEMBL
| Assay Description Inhibition of FLT3 (unknown origin) |
Bioorg Med Chem Lett 26: 4625-4630 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.063 |
More data for this Ligand-Target Pair | |